GlassScriptPhysician profile
Julius G Balogh
NPI 1588923544
$244,635.32
in general payments reported to CMS, 2019-2025
13 companies · $2,791 in 2025
The $2,791 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $448 · 2022: $90K · 2023: $97K · 2024: $54K · 2025: $2,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $134K · Travel and Lodging: $14K · Food and Beverage: $5,814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $134,443.75 |
| Travel and Lodging | $14,003.08 |
| Food and Beverage | $5,814.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $218,024.72 | 2021-2024 | Hemosphere |
| Becton, Dickinson and Company | $20,592.79 | 2024-2025 | Hemosphere |
| Instrumentation Laboratory Company | $2,400.00 | 2022 | |
| Werfen USA LLC | $1,800.00 | 2022 | |
| Abiomed | $954.47 | 2022-2025 | Impella |
| Livanova USA, INC. | $426.68 | 2021-2022 | |
| Lumenis Be INC | $152.05 | 2025 | M22 |
| Ethicon US, LLC | $111.63 | 2024-2025 | Surgicel Nu-Knit, Stratafix, Dermabond |
| Silk Road Medical, INC. | $99.46 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Corcym INC | $21.46 | 2024 | Mi Detach - Aortic Cross Clamp - Delivery System Kit |
| Terumo Medical Corporation | $21.28 | 2025 | Azur Cx Detachable |
| Ambu INC. | $15.81 | 2025 | |
| Atricure, INC. | $14.97 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julius Balogh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.